VJOncology is committed to improving our service to you

HOPA 2018 | Managing the adverse events of immune checkpoint inhibitors

VJOncology is committed to improving our service to you

Christopher Campen

Immune checkpoint inhibitors are effective in the management of various cancers. However, there are a number of side effects that are linked to the long-term use of these agents, including colitis and myocarditis. Here, Christopher Campen, PharmD, BCOP, from the GHS Cancer Institute, Greenville, SC, discusses the management of the related toxicity and the steps that can be taken to reduce these effects. This video was recorded at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference held in Denver, CO.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter